Connection

Bonaventura Clotet to Prospective Studies

Back to Details
This is a "connection" page, showing publications Bonaventura Clotet has written about Prospective Studies.
Bonaventura Clotet
Connection Strength
0.057
Prospective Studies
  1. Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study). J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):47-52.
    View in: PubMed
    Score: 0.012
  2. Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals. Viruses. 2021 06 12; 13(6).
    View in: PubMed
    Score: 0.010
  3. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021 01 28; 11(1):2608.
    View in: PubMed
    Score: 0.009
  4. Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series. Clin Microbiol Infect. 2021 Apr; 27(4):651-652.
    View in: PubMed
    Score: 0.009
  5. Routine Screening of Anal Cytology in Persons With Human Immunodeficiency Virus and the Impact on Invasive Anal Cancer: A Prospective Cohort Study. Clin Infect Dis. 2020 07 11; 71(2):390-399.
    View in: PubMed
    Score: 0.009
  6. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study. Lancet HIV. 2018 11; 5(11):e638-e646.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.